keyword
MENU ▼
Read by QxMD icon Read
search

IUS

keyword
https://www.readbyqxmd.com/read/29675718/ultrasound-guided-brain-surgery-echographic-visibility-of-different-pathologies-and-surgical-applications-in-neurosurgical-routine
#1
Domenico Policicchio, Artan Doda, Enrico Sgaramella, Stefano Ticca, Filippo Veneziani Santonio, Riccardo Boccaletti
BACKGROUND: The use of intraoperative ultrasound (iUS) has increased in the last 15 years becoming a standard tool in many neurosurgical centers. Our aim was to assess the utility of routine use of iUS during various types of intracranial surgery. We reviewed our series to assess ultrasound visibility of different pathologies and iUS applications during the course of surgery. MATERIALS AND METHODS: This is a retrospective review of 162 patients who underwent intracranial surgery with assistance of the iUS guidance system (SonoWand)...
April 19, 2018: Acta Neurochirurgica
https://www.readbyqxmd.com/read/29662538/the-accuracy-of-intestinal-ultrasound-compared-with-small-bowel-capsule-endoscopy-in-assessment-of-suspected-crohn-s-disease-in-patients-with-negative-ileocolonoscopy
#2
Dan Carter, Lior H Katz, Eytan Bardan, Eti Salomon, Shulamit Goldstein, Shomron Ben Horin, Uri Kopylov, Rami Eliakim
Background: Small bowel involvement in Crohn's disease (CD) is frequently proximal to the ileocecal valve and inaccessible by conventional ileocolonoscopy (IC). Small bowel capsule endoscopy (SBCE) is among the prime modalities for assessment of small bowel disease in these patients. Intestinal ultrasound (IUS) is an accurate bedside fast and low-cost diagnostic modality utilized in CD for both diagnosis and monitoring. The aim of this study was to examine the accuracy of IUS in patients with suspected CD after a negative IC, and to evaluate the correlation of IUS with SBCE, inflammatory biomarkers and other cross-sectional imaging techniques...
2018: Therapeutic Advances in Gastroenterology
https://www.readbyqxmd.com/read/29602870/using-program-data-to-improve-access-to-family-planning-and-enhance-the-method-mix-in-conflict-affected-areas-of-the-democratic-republic-of-the-congo
#3
Lara S Ho, Erin Wheeler
Unmet need for family planning in the conflict-affected area of eastern Democratic Republic of the Congo (DRC) has been reported to be as high as 38%, and women in such conflict settings are often the most at risk for maternal mortality. The International Rescue Committee implements the Family Planning and Post-Abortion Care in Emergencies program in 3 provinces of eastern DRC to provide women and couples access to family planning, including long-acting reversible contraceptives (LARCs). This article presents routine program data from June 2011 through December 2013 from 2 health zones as well as results from a qualitative assessment of family planning clients and of male and female non-users, conducted in 2013...
March 21, 2018: Global Health, Science and Practice
https://www.readbyqxmd.com/read/29588160/role-for-primary-immunosuppression-with-everolimus-after-pulmonary-transplantation
#4
J Salman, K Jansson, Th Siemeni, W Sommer, A-K Knoefel, L Ahrens, T Nakagiri, F Ius, I Tudorache, B Kruse, S Thissen, D Jonigk, M Strüber, A Haverich, G Warnecke, M Avsar
No abstract text is available yet for this article.
March 26, 2018: Transplant Immunology
https://www.readbyqxmd.com/read/29571176/intraoperative-ultrasound-appearance-of-a-pancreatic-cerebral-metastasis-a-case-report
#5
Carmine Antonio Donofrio, Lina Raffaella Barzaghi, Jody Filippo Capitanio, Andrea Cavalli, Pietro Panni, Silvia Snider, Pietro Mortini
BACKGROUND:  Brain metastases (BMs) derived from pancreatic adenocarcinoma (PAC) have an extremely low incidence (0.1-0.4%) and are usually associated with a very poor prognosis. The treatment strategy is palliative and includes conventional radiotherapy, stereotactic radiosurgery, chemotherapy, and surgical resection. CASE DESCRIPTION:  A 39-year-old man with a history of PAC developed a systemic tumor relapse with intracranial progression. Magnetic resonance imaging (MRI) documented a right rolandic, cortical, and cystic lesion with leptomeningeal intrasulcular extension...
March 23, 2018: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://www.readbyqxmd.com/read/29560743/bleeding-patterns-for-the-liletta-%C3%A2-levonorgestrel-52-mg-intrauterine-system
#6
Courtney A Schreiber, Stephanie B Teal, Paul D Blumenthal, Lisa M Keder, Andrea I Olariu, Mitchell D Creinin
PURPOSE: Evaluate bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system (IUS) using the World Health Organization Belsey definitions. MATERIAL AND METHODS: This prospective multicenter trial evaluates the efficacy and safety of Liletta® (Clinicaltrials.gov NCT00995150). We evaluated bleeding patterns for 1700 nulliparous and multiparous women using a daily diary completed by participants for the first 2 years and by questionnaire every 3 months thereafter...
March 21, 2018: European Journal of Contraception & Reproductive Health Care
https://www.readbyqxmd.com/read/29553761/a-bifactor-model-of-intolerance-of-uncertainty-in-undergraduate-and-clinical-samples-do-we-need-to-reconsider-the-two-factor-model
#7
Sarah Shihata, Peter M McEvoy, Barbara Ann Mullan
The theorized role that intolerance of uncertainty (IU) plays in the acquisition, maintenance, and treatment of multiple emotional disorders underscores the importance of valid assessment tools. Research using the Intolerance of Uncertainty Scale-Short form (IUS-12) has conceptualized IU along 2 dimensions, namely, prospective IU and inhibitory IU. However, recent research has cast doubt on the separability of these dimensions. The aim of the current study was to evaluate the fit of competing measurement models of the IUS-12 in separate undergraduate (N = 506) and clinical (N = 524) samples...
March 19, 2018: Psychological Assessment
https://www.readbyqxmd.com/read/29537321/risk-factors-and-the-choice-of-long-acting-reversible-contraception-following-medical-abortion-effect-on-subsequent-induced-abortion-and-unwanted-pregnancy
#8
Riina Korjamo, Oskari Heikinheimo, Maarit Mentula
OBJECTIVE: To analyse the post-abortion effect of long-acting reversible contraception (LARC) plans and initiation on the risk of subsequent unwanted pregnancy and abortion. MATERIALS AND METHODS: retrospective cohort study of 666 women who underwent medical abortion between January-May 2013 at Helsinki University Hospital, Finland. Altogether 159 (23.8%) women planning post-abortion use of levonorgestrel-releasing intrauterine system (LNG-IUS) participated in a randomized study and had an opportunity to receive the LNG-IUS free-of-charge from the hospital...
March 14, 2018: European Journal of Contraception & Reproductive Health Care
https://www.readbyqxmd.com/read/29530557/-endometriosis-medical-treatment-hormonal-treatment-for-the-management-of-pain-and-endometriotic-lesions-recurrence-cngof-has-endometriosis-guidelines
#9
S Geoffron, J Cohen, M Sauvan, G Legendre, J M Wattier, E Daraï, H Fernandez, N Chabbert-Buffet
The available literature, from 2006 to 2017, on hormonal treatment has been analysed as a contribution to the HAS-CNGOF task force for the treatment of endometriosis. Available data are heterogeneous and the general level of evidence is moderate. Hormonal treatment is usually offered as the primary option to women suffering from endometriosis. It cannot be used in women willing to conceive. In women who have not been operated, the first line of hormonal treatment includes combined oral contraceptives (COC) and the levonorgestrel-releasing intra uterine system (52mg LNG-IUS)...
March 10, 2018: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/29510966/-medical-treatment-for-the-management-of-painful-endometriosis-without-infertility-cngof-has-endometriosis-guidelines
#10
M Sauvan, N Chabbert-Buffet, M Canis, P Collinet, X Fritel, S Geoffron, G Legendre, J-M Wattier, H Fernandez
OBJECTIVE: To provide clinical practice guidelines for the management of painful endometriosis in women without infertility. METHODS: Systematic review of the literature literature since 2006, level of evidence rating, external proofreading and grading of the recommendation grade by an expert group according to HAS methodology. RESULTS: Combined hormonal contraceptives (COP) and the levonorgestrel-releasing intra-uterin system (LNG-IUS) are recommended as first-line hormonal therapies for the treatment of painful endometriosis (grade B)...
March 3, 2018: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/29486748/levonorgestrel-releasing-intrauterine-system-for-treatment-of-heavy-menstrual-bleeding-in-adolescents-with-glanzmann-s-thrombasthenia-illustrated-case-series
#11
Meiqiu Lu, Xin Yang
BACKGROUND: Glanzmann's Thrombasthenia (GT) is an inherited genetic disorder caused by defects in the platelet membrane glycoproteins IIb/IIIA, and is associated with heavy menstrual bleeding (HMB). HMB is a common complication in female patients, and many adolescent girls with this disease have issues with HMB beginning at menarche. The available treatment modalities including anti-fibrinolytics, nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies though are effective, their associated side effects, limited efficacy and the poor compliance is a challenge in management of HMB...
February 27, 2018: BMC Women's Health
https://www.readbyqxmd.com/read/29483855/the-role-of-levonorgestrel-intrauterine-systems-in-the-treatment-of-symptomatic-fibroids
#12
REVIEW
Wojciech Wrona, Anna Stępniak, Piotr Czuczwar
Uterine fibroids are considered to be the most frequently occurring tumours in females. The majority of fibroids do not require any treatment. When symptomatic, the major ailments include abnormal uterine bleeding, painful menstruation, pelvic pressure or pain, urinary problems, constipation, infertility, and recurrent pregnancy loss. Surgery remains a mainstay of symptomatic uterine fibroids therapy; however, minimally-invasive techniques and pharmacological management have become more available. The levonorgestrel intrauterine system (LNG-IUS) is a T-shaped device with a vertical stem containing a reservoir of levonorgestrel and is widely known for its contraception effect...
December 2017: Przeglad Menopauzalny, Menopause Review
https://www.readbyqxmd.com/read/29482839/levonorgestrel-releasing-intrauterine-system-use-is-associated-with-a-decreased-risk-of-ovarian-and-endometrial-cancer-without-increased-risk-of-breast-cancer-results-from-the-nowac-study
#13
Mie Jareid, Jean-Christophe Thalabard, Morten Aarflot, Hege M Bøvelstad, Eiliv Lund, Tonje Braaten
OBJECTIVE: Women with ovarian cancer have poor survival rates, which have proven difficult to improve; therefore primary prevention is important. The levonorgestrel-releasing intrauterine system (LNG-IUS) prevents endometrial cancer, and recent studies suggested that it may also prevent ovarian cancer, but with a concurrent increased risk of breast cancer. We compared adjusted risks of ovarian, endometrial, and breast cancer in ever users and never users of LNG-IUS. METHODS: Our study cohort consisted of 104,318 women from the Norwegian Women and Cancer Study, 9144 of whom were ever users and 95,174 of whom were never users of LNG-IUS...
February 23, 2018: Gynecologic Oncology
https://www.readbyqxmd.com/read/29476361/combining-clinical-and-molecular-data-to-predict-the-benefits-of-carmustine-wafers-in-newly-diagnosed-high-grade-gliomas
#14
REVIEW
Tamara Ius, Daniela Cesselli, Miriam Isola, Giovanni Toniato, Giada Pauletto, Giovanni Sciacca, Sara Fabbro, Enrico Pegolo, Simona Rizzato, Antonio Paolo Beltrami, Carla di Loreto, Miran Skrap
PURPOSE OF REVIEW: The purpose of this study was to retrospectively evaluate the use of carmustine wafers (CWs) in the management of high-grade gliomas (HGGs). The data from our monoinstitutional series was compared with studies reported in the literature. Special emphasis was placed on the evaluation of side effects and the analysis of extent of resection and molecular profile as risk factors. RECENT FINDINGS: The implantation of CWs into the resection cavity during HGG treatment to deliver localized chemotherapy, followed by the Stupp protocol, remains debated in a clinical setting, largely due to the lack of appropriate phase III studies...
February 23, 2018: Current Treatment Options in Neurology
https://www.readbyqxmd.com/read/29462709/post-insertional-pain-following-intrauterine-device-placement-among-nulliparous-adolescents
#15
K M Sinning, D C Jude, J L Yoost
STUDY OBJECTIVE: To quantify the "normal" adolescent experience after IUD insertion, in order to provide appropriate counseling for future adolescents. DESIGN: Prospective cohort study. SETTING: Marshall University Department of Obstetrics and Gynecology generalist and adolescent gynecology clinics. PARTICIPANTS: Nulliparous adolescents age 13-18 and parous adults ≥18 years receiving a levonorgestrel intrauterine system (LNG-IUS)...
February 17, 2018: Journal of Pediatric and Adolescent Gynecology
https://www.readbyqxmd.com/read/29458902/postoperative-maintenance-levonorgestrel-releasing-intrauterine-system-for-symptomatic-uterine-adenomyoma
#16
Ching-Jung Lin, Teh-Fu Hsu, Yen-Hou Chang, Ben-Shian Huang, Ling-Yu Jiang, Peng-Hui Wang, Yi-Jen Chen
OBJECTIVE: To evaluate whether a maintenance levonorgestrel-releasing intrauterine system is effective for preventing the recurrence of postoperative adenomyosis-related symptoms. MATERIALS AND METHODS: From January 2005 through December 2014, a retrospective study including 133 patients with symptomatic adenomyosis undergoing conservative uterine-sparing surgery followed by gonadotropin-releasing hormone agonist treatment was conducted. We excluded the 18 patients who did not meet the inclusion criteria...
February 2018: Taiwanese Journal of Obstetrics & Gynecology
https://www.readbyqxmd.com/read/29458551/short-and-long-term-influence-of-the-levonorgestrel-releasing-intrauterine-system-mirena%C3%A2-on-vaginal-microbiota-and-candida
#17
Gilbert Gerard Ghislain Donders, G Bellen, Kateryna Ruban, Ben Van Bulck
BACKGROUND: Recurrent vulvovaginal infections are a frequent complaint in young women in need of contraception. However, the influence of the contraceptive method on the course of the disease is not well known. AIM: To investigate the influence of the levonorgestrel-releasing intrauterine-system (LNG-IUS) on the vaginal microflora. METHODS: Short-term (3 months) and long-term (1 to 5 years) changes of vaginal microbiota were compared with pre-insertion values in 252 women presenting for LNG-IUS insertion...
March 2018: Journal of Medical Microbiology
https://www.readbyqxmd.com/read/29449327/kyleena-another-levonorgestrel-ius
#18
(no author information available yet)
A levonorgestrel (LNG) intrauterine system (IUS) known as Kyleena (Bayer PLC) received marketing authorisation from the European Medicines Agency in 2016.1 The device contains 19.5mg LNG and is licensed for contraception for up to 5 years. This is the fourth LNG IUS product to be licensed for use in the UK. The company states that Kyleena offers advantages over Mirena and Jaydess LNG IUS devices.2 Here we consider the evidence for Kyleena.
February 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29444222/extracorporeal-membrane-oxygenation-as-a-bridge-to-lung-transplantation-may-not-impact-overall-mortality-risk-after-transplantation-results-from-a-7-year-single-centre-experience
#19
Fabio Ius, Ruslan Natanov, Jawad Salman, Christian Kuehn, Wiebke Sommer, Murat Avsar, Thierry Siemeni, Dmitry Bobylev, Reza Poyanmehr, Dietmar Boethig, Joerg Optenhoefel, Nicolaus Schwerk, Axel Haverich, Gregor Warnecke, Igor Tudorache
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) has an important role in bridging patients to lung transplantation. In this study, we present our experience with pretransplant ECMO during the last 7 years and investigate its impact on graft outcomes. METHODS: Records of all lung-transplanted patients at our institution between January 2010 and April 2017 were retrospectively reviewed. Graft survival was compared between patients who required pretransplant ECMO (pre-Tx ECMO+) and patients who did not (pre-Tx ECMO-)...
February 12, 2018: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/29436865/sexual-function-and-quality-of-life-of-women-adopting-the-levonorgestrel-releasing-intrauterine-system-lng-ius-13-5%C3%A2-mg-after-abortion-for-unintended-pregnancy
#20
Salvatore Caruso, Stefano Cianci, Salvatore Giovanni Vitale, Valentina Fava, Silvia Cutello, Antonio Cianci
PURPOSE: The aim of the study was to investigate the impact of the long-acting reversible contraception (LARC) levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) on sexual function and quality of life (QoL) in women after having undergone abortion for unintended pregnancy. METHODS: In a prospective controlled study, 128 women aged 16-35 years received counseling to adopt LNG-IUS contraception after termination of pregnancy. The Visual Analog Scale (VAS), the Short Form-36 questionnaire (SF-36), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to investigate, respectively, pelvic pain levels, QoL, sexual function and sexual distress of these women at baseline (T0) and at 6 (T1) and 12 (T2) months after LNG-IUS placement...
February 13, 2018: European Journal of Contraception & Reproductive Health Care
keyword
keyword
59542
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"